CD274 and chronic myelogenous leukemia, BCR-ABL1 positive: Elevation of PD-1 in CD8+ cells was reported in cancer patients, and the blockage of PD-1/PD-L1 interaction may help to restore the function of CML-specific cytotoxic T-lymphocytes (CTLs) [27].